|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
1 | AN ACT concerning public health.
| ||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the | ||||||||||||||||||||||||
5 | Biomonitoring Safety Net Act. | ||||||||||||||||||||||||
6 | Section 5. Findings and purposes. | ||||||||||||||||||||||||
7 | (a) The General Assembly finds all of the following: | ||||||||||||||||||||||||
8 | (1) An estimated 100,000 chemicals are registered for | ||||||||||||||||||||||||
9 | use today in the United States. Another 2,000 chemicals are | ||||||||||||||||||||||||
10 | added each year. | ||||||||||||||||||||||||
11 | (2) Some toxicological screening data exists for only | ||||||||||||||||||||||||
12 | 7% to 10% of these chemicals. More than 90% of these | ||||||||||||||||||||||||
13 | chemicals have never been tested for their effects on human | ||||||||||||||||||||||||
14 | health. Large numbers of these chemicals are found in | ||||||||||||||||||||||||
15 | cosmetics, personal care products, pesticides, food dyes, | ||||||||||||||||||||||||
16 | cleaning products, fuels, and plastics. | ||||||||||||||||||||||||
17 | (3) As a result, people are exposed to chemicals daily. | ||||||||||||||||||||||||
18 | Many of these chemicals persist in the environment or | ||||||||||||||||||||||||
19 | accumulate and remain in body fat and have been shown to be | ||||||||||||||||||||||||
20 | toxic. | ||||||||||||||||||||||||
21 | (4) The Centers for Disease Control and Prevention has | ||||||||||||||||||||||||
22 | documented the presence of 148 environmental chemicals in | ||||||||||||||||||||||||
23 | the blood and urine of Americans of all ages and races. |
| |||||||
| |||||||
1 | (b) The purposes of this Act are all of the following: | ||||||
2 | (1) To establish an Environmental Contaminant | ||||||
3 | Biomonitoring Program to monitor the presence and | ||||||
4 | concentration of designated chemicals in the bodies of the | ||||||
5 | people of this State. | ||||||
6 | (2) To produce biomonitoring studies that provide data | ||||||
7 | helping scientists, researchers, public health personnel, | ||||||
8 | and community members explore linkages between chemical | ||||||
9 | exposure and health concerns. | ||||||
10 | (3) To collect biomonitoring data that supports | ||||||
11 | Illinois public health by establishing trends in chemical | ||||||
12 | exposures, validating modeling and survey methods, | ||||||
13 | supporting epidemiological studies, identifying highly | ||||||
14 | exposed communities, addressing the data gaps between | ||||||
15 | chemical exposures and specific health outcomes, informing | ||||||
16 | health responses to unanticipated emergency exposures, | ||||||
17 | assessing the effectiveness of current regulations, and | ||||||
18 | setting priorities for reform. | ||||||
19 | Section 10. Definitions. As used in this Act: | ||||||
20 | "Agency" means the Illinois Environmental Protection | ||||||
21 | Agency. | ||||||
22 | "Department" means the Department of Public Health. | ||||||
23 | "Program" means the Environmental Contaminant | ||||||
24 | Biomonitoring Program. |
| |||||||
| |||||||
1 | Section 15. Environmental biomonitoring safety net. The | ||||||
2 | Department of Public Health, in collaboration with the Illinois | ||||||
3 | Environmental Protection Agency, shall establish an | ||||||
4 | Environmental Contaminant Biomonitoring Program to monitor the | ||||||
5 | presence and concentration of designated chemicals in the | ||||||
6 | bodies of the people of this State. The Program shall utilize | ||||||
7 | biological specimens, as appropriate, to identify designated | ||||||
8 | chemicals that are present in the bodies of the people of this | ||||||
9 | State. Biomonitoring shall take place on a strictly voluntary | ||||||
10 | and confidential basis. Results reported shall not disclose | ||||||
11 | individual confidential information of participants. | ||||||
12 | Appropriate biological specimens must be used to monitor and | ||||||
13 | assess the presence and concentration of designated chemicals. | ||||||
14 | Biological specimens shall be analyzed by laboratories | ||||||
15 | operated by the Department, the Agency, or their contractors. | ||||||
16 | All participants must be evaluated for the presence of | ||||||
17 | designated chemicals as a component of the biomonitoring | ||||||
18 | process. Individual participants may request and shall receive | ||||||
19 | their complete results. When either physiological or chemical | ||||||
20 | data obtained from a participant indicate a significant known | ||||||
21 | risk, Program staff experienced in communicating biomonitoring | ||||||
22 | results shall consult with the individual and recommend | ||||||
23 | follow-up steps as appropriate. | ||||||
24 | The Program shall incorporate, as appropriate, the methods | ||||||
25 | utilized by the Centers for Disease Control and Prevention for | ||||||
26 | the studies known collectively as the National Report on Human |
| |||||||
| |||||||
1 | Exposure to Environmental Chemicals. The Department, in | ||||||
2 | collaboration with the Program, shall conduct statistical and | ||||||
3 | epidemiological analyses of the biomonitoring results. No | ||||||
4 | governmental agency or private person or entity may | ||||||
5 | discriminate against a person or community based upon the | ||||||
6 | biomonitoring results. | ||||||
7 | Section 20. Scientific Guidance Panel. In implementing the | ||||||
8 | Program, the Department and the Agency shall establish a | ||||||
9 | Scientific Guidance Panel. The Panel shall be composed of 9 | ||||||
10 | members, whose expertise shall encompass the disciplines of | ||||||
11 | public health, epidemiology, biostatistics, environmental | ||||||
12 | medicine, risk analysis, exposure assessment, developmental | ||||||
13 | biology, laboratory sciences, bioethics, maternal and child | ||||||
14 | health with a specialty in breastfeeding, and toxicology. The | ||||||
15 | Governor shall appoint 3 members to the Panel, the President of | ||||||
16 | the Senate shall appoint 3 members, and the Speaker of the | ||||||
17 | House shall appoint 3 members. Members shall be appointed for | ||||||
18 | 3-year terms, except that, with respect to the initial | ||||||
19 | appointees, each appointing power shall appoint one member for | ||||||
20 | a one-year term and one member for a 2-year term. Members may | ||||||
21 | be reappointed for additional terms without limitation. | ||||||
22 | Members shall serve until their successors are appointed and | ||||||
23 | have qualified. Vacancies shall be filled in the same manner as | ||||||
24 | the original appointments, and any member so appointed shall | ||||||
25 | serve during the remainder of the term for which the vacancy |
| |||||||
| |||||||
1 | occurred. The Panel shall meet, at a minimum, 3 times per year. | ||||||
2 | The Agency shall be responsible for staffing and administration | ||||||
3 | of the Panel. Members of the Panel shall be reimbursed for | ||||||
4 | travel and other necessary expenses incurred in the performance | ||||||
5 | of their duties under this Act, but shall not receive a salary | ||||||
6 | or compensation. | ||||||
7 | The Panel shall provide scientific peer review and make | ||||||
8 | recommendations regarding the design and implementation of the | ||||||
9 | Program, including specific recommendations for chemicals that | ||||||
10 | are priorities for biomonitoring. The Panel shall retain final | ||||||
11 | decision-making authority. The Panel shall recommend priority | ||||||
12 | chemicals for inclusion in the Program using all of the | ||||||
13 | following criteria: | ||||||
14 | (1) The degree of potential exposure to the public or | ||||||
15 | specific subgroups, including, but not limited to, certain | ||||||
16 | occupations. | ||||||
17 | (2) The likelihood of a chemical being a carcinogen or | ||||||
18 | toxicant based on peer-reviewed health data, its chemical | ||||||
19 | structure, or the toxicology of chemically related | ||||||
20 | compounds. | ||||||
21 | (3) The limits of laboratory detection for the | ||||||
22 | chemical, including the ability to detect the chemical at | ||||||
23 | levels low enough to be expected in the general population. | ||||||
24 | (4) Any other criteria the Panel deems significant. | ||||||
25 | The Panel may recommend additional designated chemicals | ||||||
26 | not included in the National Report on Human Exposure to |
| |||||||
| |||||||
1 | Environmental Chemicals for inclusion in the Program using all | ||||||
2 | of the following criteria: | ||||||
3 | (A) Exposure or potential exposure to the public or | ||||||
4 | specific subgroups. | ||||||
5 | (B) The known or suspected health effects resulting | ||||||
6 | from some level of exposure based on peer-reviewed | ||||||
7 | scientific studies. | ||||||
8 | (C) The need to assess the efficacy of public health | ||||||
9 | actions to reduce exposure to a chemical. | ||||||
10 | Section 25. Dissemination of biomonitoring findings. The | ||||||
11 | Department and the Agency shall disseminate biomonitoring | ||||||
12 | findings to the general public via appropriate media, including | ||||||
13 | governmental and other Internet websites, in a manner that is | ||||||
14 | understandable to the average person. | ||||||
15 | Section 30. Program findings; report. Every 2 years, | ||||||
16 | beginning on the effective date of this Act, the Department, in | ||||||
17 | collaboration with the Agency, shall submit a report to the | ||||||
18 | General Assembly containing the findings of the Program and | ||||||
19 | shall include in the report additional activities and | ||||||
20 | recommendations to date. Copies of the report shall be made | ||||||
21 | available via appropriate media to the public.
|